Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 10
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Analysis of outcomes and prognostic factors of acute lymphoblastic leukemia patients treated by MCP841 protocol: A regional cancer center experience

Kapoor Akhil, Kalwar Ashok, Kumar Narender, Singhal Mukesh Kumar, Beniwal Surender, Kumar Harvindra Singh

Year : 2016| Volume: 21| Issue : 1 | Page no: 15-15

   This article has been cited by
1 Association of NUDT15 c.415C>T and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia
Sunitha Kodidela,Patchava Dorababu,Dimpal N. Thakkar,Biswajit Dubashi,Rajan Sundaram,Niveditha Muralidharan,Ravi Prasad Nidanapu,Anil Aribandi,Suresh Chandra Pradhan,Chakradhara Rao Satyanarayana Uppugunduri
Genes. 2020; 11(6): 594
[Pubmed]  [Google Scholar] [DOI]
2 Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol
Avinash Pandey,Shivali Ahlawat,Anjana Singh,Shivkant Singh,Krishna Murari,Raj Aryan
Cancer Research, Statistics, and Treatment. 2020; 3(2): 183
[Pubmed]  [Google Scholar] [DOI]


Read this article